Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Kayexalate

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
BACKGROUND Sodium polystyrene sulfonate (Kayexalate; Sanofi-Aventis, Paris, France) is a cation-exchange resin routinely used in… 
2009
2009
Kayexalate (sodium polystyrene sulfonate in sorbitol) is commonly used for treatment of hyperkalemia. We describe the case of a… 
2009
2009
A 56-year-old woman with chronic kidney disease stage 3 due to diabetic glomerulopathy and focal segmental glomerulosclerosis… 
Review
2008
Review
2008
Abstract Background: Inadequately controlled chronic diseases may present a threat to life and well-being during the emergency… 
Highly Cited
2001
Highly Cited
2001
Kayexalate (sodium polystyrene sulfonate) in sorbitol has been demonstrated to cause colonic necrosis in a subset of uremic… 
Review
2001
Review
2001
Patients with renal insufficiency are particularly prone to electrolyte abnormalities, especially hyperkalemia, which can be life… 
Highly Cited
1997
Highly Cited
1997
Sodium polystyrene sulfonate (Kayexalate) in sorbitol given as an enema or orally to treat hyperkalemia has been reported to… 
1997
1997
  • G. Gardiner
  • Canadian journal of gastroenterology = Journal…
  • 1997
  • Corpus ID: 31523230
BACKGROUND Kayexalate (sodium polystyrene sulphonate) in sorbitol is commonly used to treat hyperkalemia in patients with renal… 
  • figure 1
  • figure 2
  • figure 5
  • figure 3
  • figure 6
Review
1993
Review
1993
The authors present the case of a patient who developed near total colonic necrosis shortly after renal transplantation. The… 
Highly Cited
1987
Highly Cited
1987
Five patients who suffered catastrophic colonic necrosis are presented. All patients were uremic and received sodium polystyrene…